320 related articles for article (PubMed ID: 32010120)
1. A Role for Dogs in Advancing Cancer Immunotherapy Research.
Dow S
Front Immunol; 2019; 10():2935. PubMed ID: 32010120
[TBL] [Abstract][Full Text] [Related]
2. Translational oncotargets for immunotherapy: From pet dogs to humans.
Mestrinho LA; Santos RR
Adv Drug Deliv Rev; 2021 May; 172():296-313. PubMed ID: 33705879
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy in veterinary oncology.
Bergman PJ
Vet Clin North Am Small Anim Pract; 2014 Sep; 44(5):925-39. PubMed ID: 25174908
[TBL] [Abstract][Full Text] [Related]
4. Cancer immunotherapy.
Bergman PJ
Vet Clin North Am Small Anim Pract; 2010 May; 40(3):507-18. PubMed ID: 20471533
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy for canine cancer--is it time to go back to the future?
Killick DR; Stell AJ; Catchpole B
J Small Anim Pract; 2015 Apr; 56(4):229-41. PubMed ID: 25704119
[TBL] [Abstract][Full Text] [Related]
6. Cancer Immunotherapies.
Bergman PJ
Vet Clin North Am Small Anim Pract; 2019 Sep; 49(5):881-902. PubMed ID: 31186125
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for Dogs: Running Behind Humans.
Klingemann H
Front Immunol; 2018; 9():133. PubMed ID: 29459862
[TBL] [Abstract][Full Text] [Related]
8. Cancer immunotherapy.
Bergman PJ
Top Companion Anim Med; 2009 Aug; 24(3):130-6. PubMed ID: 19732731
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous mammary tumors in mongrel dogs. A relevant model to demonstrate tumor therapeutical success by application of neuraminidase-treated tumor cells.
Sedlacek HH; Seiler FR
Dev Biol Stand; 1977 Apr 13-15; 38():399-412. PubMed ID: 608530
[No Abstract] [Full Text] [Related]
10. Remission of Spontaneous Canine Tumors after Systemic Cellular Viroimmunotherapy.
Cejalvo T; Perisé-Barrios AJ; Del Portillo I; Laborda E; Rodriguez-Milla MA; Cubillo I; Vázquez F; Sardón D; Ramirez M; Alemany R; Del Castillo N; García-Castro J
Cancer Res; 2018 Sep; 78(17):4891-4901. PubMed ID: 29991502
[TBL] [Abstract][Full Text] [Related]
11. Predictive modeling for cancer drug discovery using canine models.
Lucroy MD; Suckow MA
Expert Opin Drug Discov; 2020 Jun; 15(6):731-738. PubMed ID: 32176534
[TBL] [Abstract][Full Text] [Related]
12. Generation of a canine anti-EGFR (ErbB-1) antibody for passive immunotherapy in dog cancer patients.
Singer J; Fazekas J; Wang W; Weichselbaumer M; Matz M; Mader A; Steinfellner W; Meitz S; Mechtcheriakova D; Sobanov Y; Willmann M; Stockner T; Spillner E; Kunert R; Jensen-Jarolim E
Mol Cancer Ther; 2014 Jul; 13(7):1777-1790. PubMed ID: 24755200
[TBL] [Abstract][Full Text] [Related]
13. Comparative aspects of cancer immunotherapy: immunologic methods used for treatment of spontaneous cancer in animals.
Theilen GH; Hills D
J Am Vet Med Assoc; 1982 Nov; 181(10):1134-41. PubMed ID: 6757216
[No Abstract] [Full Text] [Related]
14. Naturally occurring cancer in pet dogs: important models for developing improved cancer therapy for humans.
Knapp DW; Waters DJ
Mol Med Today; 1997 Jan; 3(1):8-11. PubMed ID: 9021736
[TBL] [Abstract][Full Text] [Related]
15. Safety Evaluation of Autologous Tissue Vaccine Cancer Immunotherapy in a Canine Model.
Crossley RA; Matz A; Dew T; Kalinauskas A; Faucette N; Poff B; Silbart LK; Suckow MA
Anticancer Res; 2019 Apr; 39(4):1699-1703. PubMed ID: 30952708
[TBL] [Abstract][Full Text] [Related]
16. Genetic immunotherapy for cancer.
Elmslie RE; Dow SW
Semin Vet Med Surg Small Anim; 1997 Aug; 12(3):193-205. PubMed ID: 9283245
[TBL] [Abstract][Full Text] [Related]
17. Improving human cancer therapy through the evaluation of pet dogs.
LeBlanc AK; Mazcko CN
Nat Rev Cancer; 2020 Dec; 20(12):727-742. PubMed ID: 32934365
[TBL] [Abstract][Full Text] [Related]
18. Electro-gene-transfer as a new tool for cancer immunotherapy in animals.
Impellizeri JA; Ciliberto G; Aurisicchio L
Vet Comp Oncol; 2014 Dec; 12(4):310-8. PubMed ID: 23095099
[TBL] [Abstract][Full Text] [Related]
19. Antigenic enhancement of canine mammary tumours by autoimmunisation with DNP-conjugates.
Hannant D; Else RW; Crighton GW
Vet Rec; 1979 Apr; 104(15):350-1. PubMed ID: 556189
[No Abstract] [Full Text] [Related]
20. Immunological, anti-angiogenic and clinical effects of intratumoral interleukin 12 electrogene therapy combined with metronomic cyclophosphamide in dogs with spontaneous cancer: A pilot study.
Cicchelero L; Denies S; Vanderperren K; Stock E; Van Brantegem L; de Rooster H; Sanders NN
Cancer Lett; 2017 Aug; 400():205-218. PubMed ID: 27693635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
